Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBERAL Study of potassium-rich diet with rescue sodium zirconium cyclosilicate in chronic kidney disease
NL-OMON59782Phase 3Completed
- Sponsor
- Leiden University Medical Center
- Start
- May 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sodium zirconium cyclosilicate in chronic kidney disease (CKD) and hyperkalemia (2 arms), sponsored by Leiden University Medical Center. Started May 2024; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
chronic kidney disease (CKD)hyperkalemia
Beyond the preview
Go deeper on NL-OMON59782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59782.